XOMA CorporationXOMAPNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank59
Year-over-Year Change
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P59
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
82.09%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -94.66% |
| Q1 2025 | 49.65% |
| Q4 2024 | 5.75% |
| Q3 2024 | -29.63% |
| Q2 2024 | 3418.18% |
| Q1 2024 | 32.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | -35.90% |
| Q2 2023 | -27.78% |
| Q1 2023 | 92.86% |
| Q4 2022 | -3.45% |
| Q3 2022 | -27.50% |
| Q2 2022 | -28.57% |
| Q1 2022 | 33.33% |
| Q4 2021 | 40.00% |
| Q3 2021 | -21.05% |
| Q2 2021 | -37.70% |
| Q1 2021 | 69.44% |
| Q4 2020 | 5.88% |
| Q3 2020 | -10.53% |
| Q2 2020 | -38.71% |
| Q1 2020 | -52.31% |
| Q4 2019 | -9.09% |
| Q3 2019 | -80.25% |
| Q2 2019 | 182.81% |
| Q1 2019 | 8.02% |
| Q4 2018 | -62.79% |
| Q3 2018 | 69.41% |
| Q2 2018 | -12.96% |
| Q1 2018 | -34.55% |
| Q4 2017 | 114.98% |
| Q3 2017 | -89.47% |
| Q2 2017 | -26.97% |
| Q1 2017 | -51.59% |
| Q4 2016 | -4.91% |
| Q3 2016 | -36.70% |
| Q2 2016 | 0.68% |
| Q1 2016 | 0.10% |
| Q4 2015 | -22.56% |